The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had a heavier impact on certain subgroups of the population, with notable risk factors being diabetes, obesity, hypertension, cardiovascular disease and advanced age.
A new study by researchers in China and the U.S. describes a round-up of the effects of commonly used hypoglycemic drugs on the outcomes of COVID-19 in diabetic patients.
